June Off to a Poor ...
Health Care: Drugs
AMAG Pharmaceuticals Inc. (AMAG: NASDAQ)
$13.58 -0.45 | -3.21%
06/01/12 - 04:00 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 63.47M | 112.65M | 50.13M | 64.18M |
| Receivables | 6.36M | 6.23M | 27.35M | 408.00K |
| Inventories | 15.21M | 16.34M | 9.42M | 96.00K |
| Other Current Assets | 0.00 | 0.00 | 788.00K | 0.00 |
| Total Current Assets | 240.03M | 290.78M | 122.73M | 164.31M |
| Property, Plant & Equipment, Gross | 24.80M | 24.29M | 23.19M | 20.11M |
| Accumulated Depreciation & Depletion | 15.59M | 13.06M | 10.78M | 8.89M |
| Property, Plant & Equipment, Net | 9.21M | 11.24M | 12.42M | 11.22M |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 17.99M | 34.06M | 49.47M | 56.42M |
| Total Non-Current Assets | 27.19M | 45.29M | 61.89M | 67.64M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 267.22M | 336.08M | 184.62M | 231.96M |
| Accounts Payable | 3.73M | 4.55M | 5.43M | 2.30M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 38.99M | 36.71M | 37.56M | 14.39M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 2.79M | 0.00 | 0.00 |
| Other Non-Current Liabilities | 47.63M | 51.29M | 4.08M | 4.15M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 47.63M | 54.08M | 4.08M | 4.15M |
| Total Liabilities | 86.63M | 90.79M | 41.64M | 18.54M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 180.60M | 245.29M | 142.98M | 213.41M |
| Common Par | 213.00K | 211.00K | 174.00K | 170.00K |
| Additional Paid In Capital | 625.13M | 614.94M | 432.41M | 411.54M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -439.91M | -362.84M | -281.69M | -188.34M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | -4.84M | -7.03M | -7.92M | -9.96M |
| Total Capitalization | 180.60M | 245.29M | 142.98M | 213.41M |
| Total Equity | 180.60M | 245.29M | 142.98M | 213.41M |
| Total Liabilities & Stock Equity | 267.22M | 336.08M | 184.62M | 231.96M |
| Total Common Shares Outstanding | 21.31M | 21.14M | 17.36M | 17.02M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 21.19M | 20.81M | 17.11M | 16.99M |
| Diluted Weighted Shares Outstanding | 21.19M | 20.81M | 17.11M | 16.99M |
| Number of Employees | 174 | 226 | 283 | 259 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with AMAG
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorBreakout Stocks Of The Week...
- UserPelican Watch
- UserPART 1 JPMorgan 28th Annual...
- UserPART 1 JPMorgan 27th Annual...
- Userileana
- UserShawen Portfolio 1
- Userfiallo Portfolio 1
- UserTSimao Portfolio 1
- Usersggrimsley
Latest AMAG Headlines from TheStreet
- 8 Stocks Rising on Huge Volume 04.20.12 | 01:04 pm
- Biotech Stock Mailbag: Oncothyreon, Amag, Keryx Hate Mail 03.09.12 | 05:03 am
- Insiders Trading AMAG, CLWR, GTXI 03.06.12 | 10:03 am
- More Biotech Lessons Learned From JPM 2012 01.13.12 | 06:01 am
- The Next Big Thing In Biotech: 2012 Outlook
01.06.12 | 05:01 am - 5 Stocks Poised for Breakouts 11.07.11 | 09:11 am
- Next Step for Amag's Board: Fire CEO, Sell the Company. 10.21.11 | 11:10 am
- Biotech Stock Mailbag: Keryx Pharma 10.14.11 | 06:10 am
- Activist Fund Manager Ups Stake in Amag Pharma to Stop Merger With Allos 10.10.11 | 10:10 am
- Spectrum Pharma Said to Make Bid for Allos 09.21.11 | 11:09 am
Press Releases for AMAG
- AMAG Pharmaceuticals, Inc. To Present At Upcoming Investor Conferences - Business Wire 05.29.12 | 05:05 pm
- AMAG Pharmaceuticals Appoints William Heiden As President And Chief Executive Officer - Business Wire 05.09.12 | 04:05 pm
- AMAG Pharmaceuticals, Inc. To Host Conference Call On May 1, 2012 At 4:30 P.m. ET To Discuss Financial Results For The Quarter Ended March 31, 2012 - Business Wire 04.24.12 | 04:04 pm
- AMAG Pharmaceuticals Announces A Positive CHMP Opinion For The Approval Of Ferumoxytol In Europe For The Treatment Of Iron Deficiency Anemia In Adult Patients With Chronic Kidney Disease - Business Wire 04.20.12 | 09:04 am
- AMAG Pharmaceuticals Announces Preliminary Results From Its Phase III Study Evaluating Feraheme Compared To IV Iron Sucrose In Patients With Iron Deficiency Anemia - Business Wire 03.07.12 | 04:03 pm
- AMAG Pharmaceuticals, Inc. To Host Conference Call On March 7, 2012 At 4:30 P.m. ET To Discuss Feraheme Clinical Trial Results - Business Wire 03.06.12 | 04:03 pm
- AMAG Announces Fourth Quarter And Year End 2011 Financial Results - Business Wire 03.05.12 | 04:03 pm
- AMAG Pharmaceuticals, Inc. To Present At The 24th Annual ROTH Conference - Business Wire 03.02.12 | 04:03 pm
- AMAG Pharmaceuticals, Inc. To Host Conference Call On March 5, 2012 At 4:30 P.m. ET To Discuss Financial Results For The Fourth Quarter And Year Ended 2011 - Business Wire 02.23.12 | 04:02 pm
- AMAG Pharmaceuticals, Inc. To Present At Upcoming Investor Conferences - Business Wire 02.13.12 | 04:02 pm
Partner Headlines for AMAG
- AMAG Beats Riding on Feraheme Sales - Analyst Blog - Zacks 05.02.12 | 10:05 am
- AMAG Pharmaceuticals Reports Mixed Q4 Results - Benzinga 03.05.12 | 04:03 pm
- AMAG Pharmaceuticals Reports Mixed Q4 Results - Benzinga 03.05.12 | 04:03 pm
- Israel Englander's Stock Picks With Insider Purchases - Seeking Alpha 01.18.12 | 09:01 am
- 17 Breakout Stocks Boosted By Insiders - Seeking Alpha 12.30.11 | 04:12 pm
- McNicoll Lewis & Vlak Raises PT on AMAG Pharmaceuticals to $23 - Benzinga 12.12.11 | 01:12 pm
- Mid-Day Update: Stocks Pare Some Early Losses; Unemployment Claims Lift Sentiment - NASDAQ 11.17.11 | 05:11 pm
- Loss Shrinks at AMAG, CEO Departs - Analyst Blog - Zacks 11.08.11 | 10:11 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 10.26.11 | 09:10 am
- Stocks Rally on European Debt Summit Optimism; December Crude Surges Over 2% - NASDAQ 10.21.11 | 04:10 pm
